Cargando…
Release of experimental retinal vein occlusions by direct intraluminal injection of ocriplasmin
PURPOSE: Retinal vein occlusions (RVO) are a major cause of vision loss in people aged 50 years and older. Current therapeutic options limit the consequences of RVO but do not eliminate the cause. Cannulation of the involved vessel and removal of the clot may provide a more permanent solution with a...
Autores principales: | de Smet, Marc D, Stassen, Jean Marie, Meenink, Thijs C M, Janssens, Tom, Vanheukelom, Valérie, Naus, Gerrit J L, Beelen, Maarten J, Jonckx, Bart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256413/ https://www.ncbi.nlm.nih.gov/pubmed/27688592 http://dx.doi.org/10.1136/bjophthalmol-2016-309190 |
Ejemplares similares
-
Robotic Assisted Cannulation of Occluded Retinal Veins
por: de Smet, Marc D., et al.
Publicado: (2016) -
Assessment of Ocriplasmin Effects on the Vitreoretinal Compartment in Porcine and Human Model Systems
por: Jonckx, Bart, et al.
Publicado: (2017) -
Ocriplasmin in the Treatment of Vitreomacular Traction in a Patient with Central Retinal Vein Occlusion: A Case Report
por: Rosati, Alessandra, et al.
Publicado: (2018) -
Retinal breaks due to intravitreal ocriplasmin
por: Silva, Ruwan A, et al.
Publicado: (2014) -
Rhegmatogenous retinal detachment following intravitreal ocriplasmin
por: Madi, Haifa A., et al.
Publicado: (2016)